Binx Health has achieved a CE Mark for its chlamydia and gonorrhea multiplex test, which is used with the devicemaker’s Binx io platform.

The diagnostic provides a laboratory-quality, single-visit result in approximately thirty minutes for the sexually transmitted infections—two of the most common worldwide.

This new panel “enables a path to not just same day, but same visit testing and treatment, eliminating an immense barrier to care and cure,” says Howard Heller, the company’s chief medical officer.